Long-term albendazole therapy for diffuse parenchymal neurocysticercosis in an immunocompetent patient: A case report

Research output: Contribution to journalArticlepeer-review

Abstract

Rationale: Neurocysticercosis is a neglected tropical disease caused by the larvae of Taenia solium and may occur in immunocompetent people. We report a case of diffuse parenchymal neurocysticercosis mimicking tuberculous meningitis in an immunocompetent patient. Patient concerns: A 24-year-old immunocompetent woman presented with serial focal to generalized seizure, left body weakness, left abducens palsy, chronic cough, and body weight loss. She came from an area where she was unlikely to have contact with Taenia solium. Diagnosis: Diffuse parenchymal neurocysticercosis. Intervention: Valproic acid, dexamethasone and 15 months of albendazole therapy. Outcome: Complete recovery without any neurological sequelae. Lessons: Prolonged anthelminthic treatment may benefit neurocysticercosis patients with multiple cerebral parenchymal lesions.

Original languageEnglish
Pages (from-to)89-91
Number of pages3
JournalAsian Pacific Journal of Tropical Medicine
Volume16
Issue number2
DOIs
Publication statusPublished - Feb 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Long-term albendazole therapy for diffuse parenchymal neurocysticercosis in an immunocompetent patient: A case report'. Together they form a unique fingerprint.

Cite this